Monocytes and Macrophages

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 299-311

  Nares, Salvador ^a   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957754690     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50287-7     Document Type: Chapter

References (86)

1. ACTG Specimen Processing Guide Index 15 June (Oline) 2001, Available, AACTG-The Adult AIDS Clinical Trials GroupAACTG-The Adult AIDS Clinical Trials Group, (2004, 15 Feb), US Department of Health and Human Services, Division of AIDS, National Institute of Allergy and Infectious Diseases National Institutes of Health, USA. http://aactg.s-3.com/pub/download/SpecimenProcessingGuide.pdf.
2. Allen J.B., Wong H.L., Guyre P.M., Simon G.L., Wahl S.M. Association of circulating receptor Fc gamma Rill-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest 1991, 87:1773-1779.
3. Allen J.B., McCartney-Francis N., Smith P.D., et al. Expression of interleukin 2 receptors by monocytes from patients with acquired immunodeficiency syndrome and induction of monocyte interleukin 2 receptors by human immunodeficiency virus in vitro. J Clin Invest 1990, 85:192-199.
4. Alpsoy E., Kodelja V., Goerdt S., Orfanos C.E., Zouboulis Ch.C. Serum of patients with Behcet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 2003, 206:225-232.
5. Anderson C.F., Gerber J.S., Mosser D.M. Modulating macrophage function with IgG immune complexes. J Endotox Res 2002, 8:477-481.
6. Andreesen R., Osterholz J., Bross K.J., Schulz A., Luckenbach G.A., Lohr G.W. Cytotoxic effector cell function at different stages of human monocytemacrophage maturation. Cancer Res 1983, 43:5931-5936.
7. Bassøe C.F., Smith J., Sørnes S., Halstensen A., Lehmann A.K. Concurrent measurement of antigen- and antibody-dependent oxidative burst and phagocytosis in monocytes and neutrophils. Methods 2000, 2:203-220.
8. Bergh F.T., Dayyani F., Ziegler-Heitbrock L. Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta. J Neuroimmunol 2004, 146:176-188.
9. Beutler B., Hoebe K., Du X., Ulevitch R.J. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003, 74:479-485.
10. Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196:254-265.
11. Buechler C., Ritter M., Orso E., Langmann T., Klucken J., Scmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli. J Leukoc Biol 2000, 67:97-103.
12. Cabrera M., Rodriguez O., Monsalve I., Tovar R., Hagel I. Variations in the serum levels of soluble CD23, nitric oxide and IgE across the spectrum of American cutaneous leishmaniasis. Acta Trop 2003, 88:145-151.
13. Caulfield J.J., Fernandez M.H., Sousa A.R., Lane S.J., Lee T.H., Hawrylowicz C.M. Regulation of major histocompatibility complex class II antigens on human alveolar macrophages by granulocyte-macrophage colony-stimulating factor in the presence of glucocorticoids. Immunology 1999, 98:104-110.
14. Crucian B.E., Widen R.H. The use of flow cytometry to detect intracellular cytokine production in individual cells. Flow Cytometry Protocols 1998, 37-55. Humana Press, Totowa, New Jersey. M.J. Jaroszeski, H. Heller (Eds.).
15. De Almeida M.C., Cardoso S.A., Barral-Netto M. Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage. Int J Parasitol 2003, 33:153-162.
16. Dijkstra G., Zandvoort A.J., Kobold A.C., et al. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand J Gastroenterol 2002, 37:546-554.
17. Dinapoli M.R., Calderon C.L., Lopez D.M. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 1996, 183:1323-1329.
18. Fadok V.A., Henson P.M. Apoptosis: giving phosphatidylserine recognition an assist-with a twist. Curr Biol 2003, 13:R655-R657.
19. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
20. Fingerle-Rowson G., Auers J., Kreuzer E., et al. Downregulation of surface monocyte lipopolysaccharide-receptor CD14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation. J Thorac Cardiovasc Surg 1998, 115:1172-1178.
21. Fingerle-Rowson G., Auers J., Kreuzer E., Fraunberger P., Blumenstein M., Ziegler-Heitbrock L.H. Expansion of CD14+CD16+ monocytes in critically ill cardiac surgery patients. Inflammation 1998, 22:367-379.
22. Fingerle-Rowson G., Angstwurm M., Andreesen R., Ziegler-Heitbrock H.W. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy. Clin Exp Immunol 1998, 112:501-506.
23. Fonseca J.E., Edwards J.C.W., Blades S., Goulding N.J. Macrophage subpopulations in rheumatoid synovium. Reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments. Arthritis Rheum 2002, 46:1210-1216.
24. Frungieri M.B., Calandra R.S., Lustig L., et al. Number, distribution pattern, and identification of macrophages in the testes of infertile men. Fertil Steril 2002, 78:298-306.
25. Fujino S., Andoh A., Bamba S., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
26. Gallin J.I. Phagocytic cells: disorders of function. Inflammation: Basic Principles and Clinical Correlates 1992, 859. Raven Press, New York. J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.).
27. Gascon R.L., Narvaez A.B., Zhang R., et al. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. J Acquir Immune Defic Syndr 2002, 30:146-153.
28. Goldstein J.I., Goldstein K.A., Wardell K., et al. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis 2003, 170:325-332.
29. Gordon S., Lawson G.S., Rabinowitz S., Crocker P.R., Morris L., Perry V.H. Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol 1992, 181:1-37.
30. Greenwell-Wild T., Vazquez N., Sim D., et al. Mycobacterium avium infection and modulation of human macrophage gene expression. J Immunol 2002, 169:6286-6297.
31. Hauptmann S., Zwaldo-Klarwasser G., Jansen M., Klosterhalfen B., Kirkpatrick C.J. Macrophages and multicellular tumor spheroids in co-culture: a three dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. Amer J Pathol 1993, 143:1406-1415.
32. Högger P., Dreier J., Droste A., Buck F., Sorg C. RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998, 161:1883-1905.
33. Huissoon A.P., Emery P., Bacon P.A., Gordon J., Salmon M. Increased expression of CD23 in rheumatoid synovitis. Scand J Rheumatol 2000, 29:154-159.
34. Hume D.A., Ross I.L., Himes S.R., Sasmono R.T., Wells C.A., Ravus T. The mononuclear phagocyte system revisited. J Leuk Biol 2002, 72:621-627.
35. Izikson L., Klein R.S., Luster A.D., Weiner H.L. Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 2002, 103:125-131.
36. Kampalath B., Cleveland R.P., Chang C.C., Kass L. Monocytes with altered phenotypes in posttrauma patients. Arch Pathol Lab Med 2003, 127:1580-1585.
37. Kolb-Maurer A., Weissinger F., Kurzai O., Maurer M., Wilhelm M., Goebel W. Bacterial infection of human hematopoietic stem cells induces monocytic differentiation. FEMS Immunol Med Microbiol 2004, 40:147-153.
38. Koller M., Aringer M., Kiener H., et al. Expression of adhesion molecules on synovial fluid and peripheral blood monocytes in patients with inflammatory joint disease and osteoarthritis. Ann Rheum Dis 1999, 58:709-712.
39. Kristianson M., Graverson J., Jacobsen J., et al. Identification of the haemoglobin scavenger receptor. Nature 2001, 409:198-201.
40. Lehmann A.K., Sørnes S., Halstensen A. Phagocytosis: measurement by flow cytometry. J Immunol Methods 2000, 243:229-242.
41. Lendemans S., Kreuzfelder E., Waydhas C., Nast-Kolb D., Flohe S. Clinical course and prognostic significance of immunological and functional parameters after severe trauma. Unfallchirurg 2004, 107:203-210.
42. Lin M., Rikihisa Y. Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol 2004, 6:175-186.
43. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
44. Masuda M., Morimoto T., De Haas M., et al. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis. J Rheumatol 2003, 30:1911-1917.
45. Masuda M., Morimoto T., Kobatake S., et al. Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin Exp Immunol 2003, 132:477-484.
46. Matsushita N., Kashiwagi M., Wait R., et al. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD 163 by TIMP-3. Clin Exp Immunol 2002, 130:156-161.
47. Mazzarella G., Grella E., D'Auria D., et al. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-alpha in asthmatic patients. Allergy 2000, 55(Suppl 61):36-41.
48. Miller L.S., Atabai K., Nowakowski M., et al. Increased expression of CD23 (Fc(epsilon) receptor II) by peripheral blood monocytes of aids patients. AIDS Res Hum Retroviruses 2001, 17:443-452.
49. Møller H.J., de Fost M., Aerts H., Hollak C., Moestrup S.K. Plasma level of the macrophage-derived soluble CD163 is increase and positively correlates with severity in Gaucher's disease. Eur J Haematol 2004, 72:135-139.
50. Møller H.J., Aerts H., Grønb high symbol k H., et al. Soluble CD163: a marker for monocyte/macrophage activity in disease. Scan J Clin Lab Invest 2002, 62(Suppl):29-34.
51. Mouri T. Induction of IgE-Fc receptor (FcRII/CD23) expression on stimulated monocytes by mite allergen in patients with asthma. Jpn J Allergol 1993, 42:1683-1691.
52. Mytar B., Baran J., Gawlicka M., Ruggiero I., Zembala M. Immunophenotypic changes and induction of apoptosis of monocytes and tumour cells during their interactions in vitro. Anticancer Res 2002, 22:2789-2796.
53. Nascimento F.R.F., Rodríquez D., Gomes E., Fernvik E.C., Russo M. A method for multiple sequential analysis of macrophage functions using a small single cell sample. Braz J Med Bio Res 2003, 36:1221-1226.
54. Nielsen O.H., Kirman I., Rudiger N., Hendel J., Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003, 38:180-185.
55. Oehling A.G., Akdis C.A., Schapowal A., Blaser K., Schmitz M., Simon H.U. Suppression of the immune system by oral glucocorticoid therapy in bronchail asthma. Allergy 1997, 52:144-154.
56. Perticarari S., Presani G., Banfi E. A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 1994, 170:117-124.
57. Perticarari S., Presani G., Mangiarotti M.A., Banfi E. Simultaneous flow cytometric method to measure phagocytosis and oxidative products by neutrophils. Cytometry 1991, 12:687-693.
58. Philippidis P., Mason J.C., Evans B.J., et al. Hemaglobin scavenger receptor CD163 mediates interleukin release and heme oxygenase-1 synthesis. Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004, 94:119-126.
59. Plesner A. Increasing the yield of human mononuclear cells and low serum concentrations for in vitro generation of macrophages with M-CSF. J Immunol Methods 2003, 279:287-295.
60. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4:71-78.
61. Pulliam L., Gascon R., Stubblebine M., McGuire D., McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet 1997, 349:629-695.
62. Rakoff-Nahoum S., Chen H., Kraus T., et al. Regulation of class II expression in monocytic cells after HIV-1 infection. J Immunol 2001, 167:2331-2342.
63. Sbrana S., Parri M.S., De Filippis R., Gianetti J., Clerico A. Monitoring of monocyte functional state after extracorporeal circulation: A flow cytometry study. Cytometry 2004, 58:17-24.
64. Scherberich J.E. Proinflammatory blood monocytes: main effector and target cells in systemic and renal disease; background and therapeutic implications. Int J Clin Pharmacol Ther 2003, 41:459-464.
65. Schoppmann S.F., Briner P., Stockl J., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002, 161:947-956.
66. Shumilla J.A., Lacaille V., Hornell T.M., et al. Bordetella pertussis infection of primary human monocytes alters HLA-DR expression. Infect Immun 2004, 72:1450-1462.
67. Simone N.L., Paweletz C.P., Charboneau L., Petricoin E.F., Liotta L.A. Laser capture microdissection: beyond functional genomics to proeeomics. Mol Diagn 2000, 5:301-307.
68. Stewart C.C., Steinkamp J.A. Quantitation of cell concentration using the flow cytometer. Cytometry 1982, 2:238-243.
69. Sulahian T.H., Högger P., Wahner A.E., et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000, 12:1312-1321.
70. Swingler S., Brichacek B., Jacque J.M., Ulich C., Zhou J., Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003, 424:213-219.
71. Takemura R., Werb Z. Secretory products of macrophages and their physiological functions. Amer J Physiol 1984, 246:C1-C9.
72. Trillo-Pazos G., Diamanturos A., Rislove L., et al. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003, 13:144-154.
73. Tuomisto T.T., Korleela A., Rutanen J., et al. Gene expression in macrophage-rich inflammatory infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array. Arterioscler Thromb Vasc Biol 2003, 23:2235-2240.
74. Ugurel S., Uhlig D., Pfohler C., Tilgen W., Schadendorf D., Reinhold U. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients. Cancer Immunol Immunother Jan 16 2004, (Epub ahead of print).
75. van Furth R. Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes. Ann NY Acad Sci 1976, 278:161-175.
76. VanderBorght A., Geusens P., Raus J., Stinissen P. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 2001, 31:160-175.
77. Viksman M.Y., Bochner B.S., Peebles R.S., Schleimer R.P., Liu M.C. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin Immunol 2002, 104:77-85.
78. Vouldoukis I., Issaly F., Fourcade C., et al. CD23 and IgE expression during human immune response to cutaneous leishmaniasis: possible role in monocyte activation. Res Immunol 1994, 145:17-27.
79. Wahl L.M., Smith P.D. Isolation of monocyte/macrophage populations. Current Protocols in Immunology 1997, 2:7.6.1-7.6.8. John Wiley & Sons, Inc., Indianapolis.
80. Wahl L.M., Katona R.L., Winter C.C., Haraoui B., Scher I., Wahl S.M. Isolation of human mononuclear cells subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cell Immunol 1984, 85:373-383.
81. Wahl S.M., Chen W. TGF-beta: how tolerant can it be?. Immunol Res 2003, 28:167-179.
82. Wahl S.M., Allen J.B., Welch G.R., Wong H.L. Transforming growth factor-beta in synovial fluids modulates Fc gamma RII (CD16) expression on mononuclear phagocytes. J Immunol 1992, 148:485-490.
83. West M.A., Heagy W. Endotoxin tolerance: A review. Crit Care Med 2002, 30:64-73.
84. Wijngaarden S., van Roon J.A., Bijlsma J.W., van de Winkel J.G., Lafeber F.P. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford) 2003, 42:681-688.
85. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
86. Zisman D.A., Kunkel S.L., Streiter R.M., et al. Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 1997, 8:349-356.